Oseltamivir phos 75 MG capsule UD 10S
Ended Awarded Last action
- Contract number
- SPE2DR26FZ4NR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,746
Award facts
- Contract value 100% obligated
- $3,745.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10s). This firm fixed price delivery order, valued at $3,745.80, represents a pediatric or small-quantity medical supply requirement for antiviral pharmaceutical support. The contract is non-set-aside and competitively awarded, with an ultimate completion date of December 2, 2025, and performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.9 billion prime vendor agreement valued through December 2026 that serves as the primary vehicle for pharmaceutical procurement across the Department of Defense and other federal healthcare systems.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains and demonstrates consistent capability to meet federal procurement standards through competitive award processes. As a child contract under the DLA's broader pharmaceutical prime vendor program, this delivery order exemplifies the company's role in supplying essential medications to support defense health operations globally.
Quick answers
Who was awarded contract SPE2DR26FZ4NR?
SPE2DR26FZ4NR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FZ4NR worth?
The government has obligated $3,746 on SPE2DR26FZ4NR.
Is contract SPE2DR26FZ4NR an order under another contract?
Yes. SPE2DR26FZ4NR is a delivery order under SPE2DR25D1050, an indefinite delivery contract.
Was contract SPE2DR26FZ4NR competed?
The extent of competition for SPE2DR26FZ4NR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award